Literature DB >> 9707025

Iron overload in bone marrow transplant recipients.

S I Strasser1, K V Kowdley, G E Sale, G B McDonald.   

Abstract

We examined the degree of hepatic iron overload in patients receiving marrow transplant for hematologic malignancy and evaluated a new method of morphometric analysis of marrow iron content as a means of estimating hepatic iron stores in these patients. The iron content of marrow and liver specimens from 10 consecutive patients who died between 50 and 100 days after transplant was determined by spectrophotometry. Their mean age was 34.9 years (range 10-59). The mean time to death from disease onset was 2.2 years (0.5-8.7). Patients had received 30.2 +/- 17.4 units of red cells during the transplant period and 47.6 +/- 25.9 red cell units from diagnosis to death. The median hepatic iron concentration (HIC) was 4307 microg/g dry weight (range 1832-13120; normal 530-900) and the median hepatic iron index (HIC (micromol/g dry weight/age (years)) was 3.85 (0.76-8.14). The median biochemical marrow iron content was 1999 microg/g dry weight (range 932-3942). Morphometric analysis of the marrow iron content was performed on digital photomicrographs of a single Prussian blue-stained section of marrow. Strong correlations were demonstrated between morphometric marrow iron content and (1) biochemical marrow iron content (r = 0.8, P= 0.006) and (2) biochemical hepatic iron index (r = 0.82, P = 0.004). We conclude that marrow transplant recipients have a high liver iron content at 50-100 days post transplant with the hepatic iron index in the hereditary hemochromatosis range. Computerized morphometric marrow iron determination is a readily available means of estimating hepatic iron stores in these patients.

Entities:  

Mesh:

Year:  1998        PMID: 9707025     DOI: 10.1038/sj.bmt.1701301

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  15 in total

Review 1.  Hematopoietic stem cell transplantation for MDS.

Authors:  Matthias Bartenstein; H Joachim Deeg
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

2.  Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection.

Authors:  A Ohmoto; S Fuji; A Miyagi-Maeshima; S-W Kim; K Tajima; T Tanaka; K Okinaka; S Kurosawa; Y Inamoto; H Taniguchi; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2017-05-15       Impact factor: 5.483

3.  Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.

Authors:  Tahereh Rostami; Seyed Mostafa Monzavi; Hossein Poustchi; Ali Reza Khoshdel; Maryam Behfar; Amir Ali Hamidieh
Journal:  Int J Hematol       Date:  2020-10-08       Impact factor: 2.490

4.  National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.

Authors:  Michael L Nieder; George B McDonald; Aiko Kida; Sangeeta Hingorani; Saro H Armenian; Kenneth R Cooke; Michael A Pulsipher; K Scott Baker
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-01       Impact factor: 5.742

5.  Iron overload during follow-up after tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma.

Authors:  Soo Jin Bae; Christine Kang; Ki Woong Sung; Hee Won Chueh; Meong Hi Son; Soo Hyun Lee; Keon Hee Yoo; Hong Hoe Koo
Journal:  J Korean Med Sci       Date:  2012-03-21       Impact factor: 2.153

6.  Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation.

Authors:  Carlos Vallejo; Montserrat Batlle; Lourdes Vázquez; Carlos Solano; Antonia Sampol; Rafael Duarte; Dolores Hernández; Javier López; Montserrat Rovira; Santiago Jiménez; David Valcárcel; Vicente Belloch; Mónica Jiménez; Isidro Jarque
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

Review 7.  Iron overload, hematopoietic cell transplantation, and graft-versus-host disease.

Authors:  H Joachim Deeg; Emily Spaulding; Howard M Shulman
Journal:  Leuk Lymphoma       Date:  2009-10

8.  Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice.

Authors:  Steven Bair; Emily Spaulding; Jaakko Parkkinen; Howard M Shulman; Vladimir Lesnikov; Mary Beauchamp; François Canonne-Hergaux; Kris V Kowdley; H Joachim Deeg
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113

9.  Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia.

Authors:  S-E Lee; S-A Yahng; B-S Cho; K-S Eom; Y-J Kim; H-J Kim; C-K Min; S Lee; S-G Cho; D-W Kim; W-S Min; J W Lee
Journal:  Bone Marrow Transplant       Date:  2016-05-23       Impact factor: 5.483

Review 10.  The Role of Iron in Benign and Malignant Hematopoiesis.

Authors:  Sayantani Sinha; Joana Pereira-Reis; Amaliris Guerra; Stefano Rivella; Delfim Duarte
Journal:  Antioxid Redox Signal       Date:  2021-01-07       Impact factor: 7.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.